Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures
Zafar S, Sivaraju A, Rubinos C, Ayub N, Awodutire P, McKee Z, Chandan P, Byrnes M, Bhansali S, Rice H, Smith-Ayala A, Haider M, Tveter E, Erlich-Malona N, Ibanhes F, DeMarco A, Lewis S, Dhakar M, Punia V. Antiseizure Medication Use and Outcomes After Suspected or Confirmed Acute Symptomatic Seizures. JAMA Neurology 2024, 81 PMID: 39312247, PMCID: PMC11420826, DOI: 10.1001/jamaneurol.2024.3189.Peer-Reviewed Original ResearchAssociated with increased oddsAcute symptomatic seizuresAntiseizure medication treatmentDischarge prescriptionsSymptomatic seizuresAntiseizure medicationsElectrographic seizuresContinuous electroencephalographyOdds of treatmentGlasgow Outcome Scale scoreNeurological intensive care unitOptimal treatment durationMulticenter cohort studyAntiseizure medication useOutcome Scale scorePrescribed antiseizure medicationsAssociated with functional outcomeIntensive care unitAssociated with outcomeMain OutcomesProgressive brain injuryASM treatmentMedication useCohort studyEpileptiform abnormalitiesCharacteristics and Attendance of Patients Eligible for the PASS Clinic: A Transition of Care Model After Acute Symptomatic Seizures.
Byrnes M, Thompson N, Hantus S, Fesler J, Ying Z, Ayub N, Rubinos C, Zafar S, Sivaraju A, Punia V. Characteristics and Attendance of Patients Eligible for the PASS Clinic: A Transition of Care Model After Acute Symptomatic Seizures. Neurology Clinical Practice 2024, 14: e200232. PMID: 38213398, PMCID: PMC10781564, DOI: 10.1212/cpj.0000000000200232.Peer-Reviewed Original ResearchAntiseizure medicationsClinic attendanceASY patientsClinic modelCare modelCause-specific Cox proportional hazards modelsMedicare/Medicaid insuranceCox proportional hazards modelAcute symptomatic seizuresClinic attendance ratesClinic visit attendanceEarly postdischarge mortalityProgressive brain injuryRetrospective cohort studyAttendance of patientsRoutine clinical careProportional hazards modelDischarge planning processASM discontinuationAutoimmune encephalitisPostdischarge mortalitySymptomatic seizuresVisit attendanceSeizure clinicCohort study